Their TIF® procedure is performed without external incisions and offers patients an alternative treatment option to correct the underlying cause of GERD, eliminating esophageal inflammation and reducing the need for daily PPI medications. The company's EsophyX® technology is a clinically-backed tool for physicians to reconstruct the gastroesophageal valve and prevent stomach acids from washing back up into the esophagus, with the device being inserted through the patient's mouth with direct visual guidance from an endoscope.